GWMIA
MRNA icon

Global Wealth Management Investment Advisory’s Moderna MRNA Stock Holding History

Global Wealth Management Investment Advisory’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-181
Closed -$18.7K – 490
2023
Q3 		$18.7K Buy
181
+101
+126% +$11.3K 0.01% 247
2023
Q2 		$9.72K Buy
+80
New +$10.7K ﹤0.01% 294
2022
Q3 		– Sell
-265
Closed -$38K – 345
2022
Q2 		$38K Sell
265
-15
-5% -$2.14K 0.01% 197
2022
Q1 		$48K Buy
280
+51
+22% +$8.59K 0.01% 197
2021
Q4 		$58K Buy
229
+117
+104% +$34.2K 0.02% 183
2021
Q3 		$43K Sell
112
-18
-14% -$6.64K 0.01% 210
2021
Q2 		$31K Sell
130
-20
-13% -$3.57K 0.01% 217
2021
Q1 		$20K Sell
150
-75
-33% -$10.9K 0.01% 245
2020
Q4 		$24K Sell
225
-285
-56% -$28.8K 0.01% 223
2020
Q3 		$36K Sell
510
-50
-9% -$3.49K 0.02% 194
2020
Q2 		$36K Buy
560
+310
+124% +$17K 0.02% 219
2020
Q1 		$7K Buy
+250
New +$5.75K ﹤0.01% 380

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Global Wealth Management Investment Advisory's MRNA Position: Q4 2023 in Review

Global Wealth Management Investment Advisory sold out of Moderna (MRNA) in Q4 2023, closing a stake of 181 shares — an estimated $18.7K sold.

Global Wealth Management Investment Advisory first reported a position in MRNA in Q1 2020 and held it in 12 quarters. The position peaked at $58K in Q4 2021. 885 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Global Wealth Management Investment Advisory reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 181 Moderna shares in Q4 2023, an estimated $18.7K.
  • Global Wealth Management Investment Advisory first reported a position in Moderna in Q1 2020 and held it in 12 quarters.
  • Global Wealth Management Investment Advisory's Moderna position peaked at $58K in Q4 2021.
  • 885 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Global Wealth Management Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.